Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Accumulated Expenses (2019 - 2026)

Profound Medical has reported Accumulated Expenses over the past 5 years, most recently at $2.3 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 232.44% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, up 232.44%, while the annual FY2025 figure was $2.3 million, 232.44% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $2.3 million at Profound Medical, up from $2.2 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $3.4 million in Q1 2025 and troughed at $706000.0 in Q4 2024.
  • A 3-year average of $2.2 million and a median of $2.3 million in 2024 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: plummeted 70.81% in 2024 and later surged 232.44% in 2025.
  • Year by year, Accumulated Expenses stood at $2.4 million in 2023, then plummeted by 70.81% to $706000.0 in 2024, then surged by 232.44% to $2.3 million in 2025.
  • Business Quant data shows Accumulated Expenses for PROF at $2.3 million in Q4 2025, $2.2 million in Q3 2025, and $2.0 million in Q2 2025.